Literature DB >> 6763788

Trichomonas vaginalis: alternative pathway activation of complement.

T W Holbrook, R J Boackle, J Vesely, B W Parker.   

Abstract

Serum from adult human donors lysed Trichomonas vaginalis. The lytic effect was eliminated by heat-inactivation of serum (56 degrees C, 30 min). No serum donor exhibited significantly increased antibody against the parasite as measured by indirect immunofluorescence. Treatment of serum with ethylene glycol-bis (B-aminoethyl ether)-N, N-tetraacetic acid to eliminate classical pathway complement activation did not prevent C3 leads to C3i conversion in serum incubated with T. vaginalis. Release of complement products during alternative pathway activation may contribute to pathogenesis of trichomonal vaginitis.

Entities:  

Mesh:

Year:  1982        PMID: 6763788     DOI: 10.1016/0035-9203(82)90140-7

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  4 in total

1.  Characterization of Tritrichomonas foetus antigens by use of monoclonal antibodies.

Authors:  J L Hodgson; D W Jones; P R Widders; L B Corbeil
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

2.  Inducible immunity to Trichomonas vaginalis in a mouse model of vaginal infection.

Authors:  M C Abraham; M Desjardins; L G Filion; G E Garber
Journal:  Infect Immun       Date:  1996-09       Impact factor: 3.441

3.  Differential susceptibility of fresh Trichomonas vaginalis isolates to complement in menstrual blood and cervical mucus.

Authors:  P Demes; A Gombosová; M Valent; A Jánoska; H Fabusová; M Petrenko
Journal:  Genitourin Med       Date:  1988-06

4.  Detection and characterization of serum antitrichomonal antibodies in urogenital trichomoniasis.

Authors:  M Cogne; P Brasseur; J J Ballet
Journal:  J Clin Microbiol       Date:  1985-04       Impact factor: 5.948

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.